VANECK PHARMACEUTICAL ETF (PPH) Institutional Ownership Changes & 13F Activity
VANECK PHARMACEUTICAL ETF (PPH). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Jane Street Group, Llc, Royal Bank Of Canada, Susquehanna International Group, Llp, Goldman Sachs Group Inc, and Gts Securities Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Sell | -33,915 | -50.6% | 33,171 | $3.63M | Q2 2026 | Sep 02, 2026 |
| Copia Wealth Management | Sell | -214 | -6.3% | 3,196 | $349.48K | Q2 2026 | Aug 18, 2026 |
| Beacon Pointe Advisors, Llc | Buy | +4 | +0.1% | 3,592 | $392.83K | Q2 2026 | Aug 18, 2026 |
| Jefferies Financial Group Inc. | Sell | -24,706 | -88.2% | 3,315 | $362.50K | Q2 2026 | Aug 17, 2026 |
| Centaurus Financial, Inc. | Buy | +1,273 | — | 1,273 | $139.00K | Q2 2026 | Aug 17, 2026 |
| Equitable Holdings, Inc. | Sell | -194 | -1.4% | 14,048 | $1.54M | Q2 2026 | Aug 17, 2026 |
| Jane Street Group, Llc | Sell | -808,238 | -99.6% | 3,061 | $334.72K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Sell | -265,531 | -73.6% | 95,470 | $10.44M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +197,450 | +234.5% | 281,661 | $30.80M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +192,862 | +19.6% | 1,178,974 | $128.92M | Q2 2026 | Aug 14, 2026 |
| Gts Securities Llc | Sell | -165,483 | -81.8% | 36,942 | $4.04M | Q2 2026 | Aug 14, 2026 |
| Flow Traders U.S. Llc | Sell | -73,665 | -89.4% | 8,706 | $952.00K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -63,910 | -44.5% | 79,699 | $8.72M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +18,291 | +64.8% | 46,536 | $5.09M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Securities, Llc | Sell | -14,291 | -64.8% | 7,770 | $849.65K | Q2 2026 | Aug 14, 2026 |
| Aspen Grove Capital, Llc | Sell | -9,224 | -49.4% | 9,452 | $1.03M | Q2 2026 | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Buy | +7,860 | — | 7,860 | $859.49K | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +4,961 | — | 4,961 | $542.47K | Q2 2026 | Aug 14, 2026 |
| Raymond James Financial Inc | Buy | +2,732 | +13.6% | 22,863 | $2.50M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +2,452 | +40.1% | 8,567 | $936.80K | Q2 2026 | Aug 14, 2026 |
| Jones Financial Companies Lllp | Sell | -2,009 | -19.5% | 8,285 | $906.66K | Q2 2026 | Aug 14, 2026 |
| Ifg Advisory, Llc | Buy | +1,751 | — | 1,751 | $191.47K | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Buy | +1,433 | +10.1% | 15,610 | $1.71M | Q2 2026 | Aug 14, 2026 |
| &Partners | Buy | +1,084 | +9.1% | 12,954 | $1.42M | Q2 2026 | Aug 14, 2026 |
| Thrivent Financial For Lutherans | Buy | +904 | +4.4% | 21,546 | $2.36M | Q2 2026 | Aug 14, 2026 |
| Orion Porfolio Solutions, Llc | Sell | -676 | -3.0% | 21,563 | $2.36M | Q2 2026 | Aug 14, 2026 |
| Blue Chip Partners, Llc | Sell | -513 | -13.2% | 3,376 | $369.11K | Q2 2026 | Aug 14, 2026 |
| Strategy Asset Managers Llc | Buy | +492 | +25.3% | 2,433 | $266.05K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Sell | -169 | -39.2% | 262 | $28.69K | Q2 2026 | Aug 14, 2026 |
| Forum Finance Group S.A. | Buy | +135 | +31.4% | 565 | $50.00K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about PPH activity
Which institutional owners are buying PPH?
Institutional owners buying PPH include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in PPH activity?
"Buy" means an investor increased their reported position in PPH compared to the prior reporting period. This reflects growing exposure to VANECK PHARMACEUTICAL ETF (PPH) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in PPH increasing?
Institutional interest in PPH can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.